Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06534801Not yet recruiting
Open-label trial of oxycodone in acute postoperative pain (2 arms). Primary endpoint: Median Effective Dose. Planned start Sep 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06534801.